These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6384963)

  • 1. [Hypertension in obesity].
    Skórka B; Chlebus H
    Pol Tyg Lek; 1984 Apr; 39(15):513-7. PubMed ID: 6384963
    [No Abstract]   [Full Text] [Related]  

  • 2. Mineralocorticoid-stimulating activity of adipose tissue.
    Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on the etiology of hypertension--summarizing studies in 20th century. 4. Pathogenesis of hypertension--kidney as a pathogenetic organ of hypertension.
    Hayashi K
    Intern Med; 2001 Feb; 40(2):153-6. PubMed ID: 11300152
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension, obesity, and the renin-angiotensin system: a tale of tight associations.
    Sibley S
    Minn Med; 2003 Jan; 86(1):46-8. PubMed ID: 12585560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity hypertension, salt sensitivity and insulin resistance.
    Rocchini AP
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension: perspectives.
    Beyer KH; Peuler JD
    Pharmacol Rev; 1982 Dec; 34(4):287-313. PubMed ID: 6763701
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue.
    Aghamohammadzadeh R; Heagerty AM
    Ann Med; 2012 Jun; 44 Suppl 1():S74-84. PubMed ID: 22713152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
    Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
    J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome.
    Fujita T
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):181-3. PubMed ID: 17094057
    [No Abstract]   [Full Text] [Related]  

  • 12. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Obesity and hypertension. Prevalence, pathogenesis and clinical significance].
    Palumbo G; Schenardi F; Ronchi E; Lucchelli PD
    Recenti Prog Med; 1984 Sep; 75(9):844-56. PubMed ID: 6393245
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
    Blaj S; Stanciu S; Jurcut C; Ciobîcă L
    Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and variance in the course of hypertension].
    Shkhvatsabaia IK
    Kardiologiia; 1985 Jun; 25(6):5-12. PubMed ID: 4046312
    [No Abstract]   [Full Text] [Related]  

  • 16. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of abnormal renal sodium handling in obesity hypertension.
    Hall JE
    Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension.
    Pausova Z
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):173-8. PubMed ID: 16481885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiopathogenesis of primary hypertension].
    Günther B
    Rev Med Chil; 1984 Sep; 112(9):939-47. PubMed ID: 6099906
    [No Abstract]   [Full Text] [Related]  

  • 20. Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.
    Littlejohn NK; Grobe JL
    Am J Physiol Regul Integr Comp Physiol; 2015 Dec; 309(12):R1463-73. PubMed ID: 26491099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.